학술논문

Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: in-vitro and in-vivo evaluation.
Document Type
Article
Source
Drug Development & Industrial Pharmacy; Mar2024, Vol. 50 Issue 3, p223-235, 13p
Subject
ANTINEOPLASTIC agents
DEFERASIROX
CANCER treatment
BREAST cancer
IRON overload
ZETA potential
Language
ISSN
03639045
Abstract
Copyright of Drug Development & Industrial Pharmacy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)